X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ABBOTT INDIA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ABBOTT INDIA PFIZER/
ABBOTT INDIA
 
P/E (TTM) x 23.8 32.6 73.0% View Chart
P/BV x 3.8 8.1 46.5% View Chart
Dividend Yield % 0.9 0.8 103.8%  

Financials

 PFIZER   ABBOTT INDIA
EQUITY SHARE DATA
    PFIZER
Mar-16
ABBOTT INDIA
Mar-16
PFIZER/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2,7246,015 45.3%   
Low Rs1,6113,707 43.5%   
Sales per share (Unadj.) Rs440.91,236.9 35.6%  
Earnings per share (Unadj.) Rs48.7122.2 39.9%  
Cash flow per share (Unadj.) Rs75.8129.0 58.7%  
Dividends per share (Unadj.) Rs15.0035.00 42.9%  
Dividend yield (eoy) %0.70.7 96.1%  
Book value per share (Unadj.) Rs462.9521.2 88.8%  
Shares outstanding (eoy) m45.7521.25 215.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.9 125.1%   
Avg P/E ratio x44.539.8 111.9%  
P/CF ratio (eoy) x28.637.7 75.9%  
Price / Book Value ratio x4.79.3 50.2%  
Dividend payout %30.828.6 107.5%   
Avg Mkt Cap Rs m99,163103,296 96.0%   
No. of employees `0002.93.0 97.7%   
Total wages/salary Rs m2,7583,370 81.8%   
Avg. sales/employee Rs Th6,981.78,891.8 78.5%   
Avg. wages/employee Rs Th954.51,140.0 83.7%   
Avg. net profit/employee Rs Th771.1878.3 87.8%   
INCOME DATA
Net Sales Rs m20,17026,284 76.7%  
Other income Rs m857504 170.0%   
Total revenues Rs m21,02826,789 78.5%   
Gross profit Rs m4,3103,665 117.6%  
Depreciation Rs m1,239144 857.8%   
Interest Rs m58 64.2%   
Profit before tax Rs m3,9234,017 97.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,7941,421 126.3%   
Profit after tax Rs m2,2282,596 85.8%  
Gross profit margin %21.413.9 153.2%  
Effective tax rate %45.735.4 129.3%   
Net profit margin %11.09.9 111.8%  
BALANCE SHEET DATA
Current assets Rs m16,29914,446 112.8%   
Current liabilities Rs m7,5944,725 160.7%   
Net working cap to sales %43.237.0 116.7%  
Current ratio x2.13.1 70.2%  
Inventory Days Days6551 127.0%  
Debtors Days Days2620 131.7%  
Net fixed assets Rs m8,6221,113 774.7%   
Share capital Rs m458213 215.3%   
"Free" reserves Rs m20,72210,808 191.7%   
Net worth Rs m21,18011,076 191.2%   
Long term debt Rs m250-   
Total assets Rs m29,13716,241 179.4%  
Interest coverage x755.5497.0 152.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.71.6 42.8%   
Return on assets %7.716.0 47.8%  
Return on equity %10.523.4 44.9%  
Return on capital %19.036.3 52.3%  
Exports to sales %0.10.6 9.7%   
Imports to sales %17.512.6 138.3%   
Exports (fob) Rs m12162 7.4%   
Imports (cif) Rs m3,5263,322 106.1%   
Fx inflow Rs m52268 19.3%   
Fx outflow Rs m1403,927 3.6%   
Net fx Rs m-88-3,659 2.4%   
CASH FLOW
From Operations Rs m3,4362,514 136.7%  
From Investments Rs m-6,991-800 874.4%  
From Financial Activity Rs m-619-803 77.1%  
Net Cashflow Rs m-4,174912 -457.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.1 138.6%  
Shareholders   85,207 18,270 466.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   GLENMARK PHARMA  FULFORD INDIA  MERCK LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Energy Stocks Witness Buying(11:30 am)

After opening the day in green, Share markets in India witnessed volatile trading activity and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 22, 2017 01:19 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS